New Drug Approvals Transform Gonorrhea Treatment
Kilder
- Nature: Science sleuths raise concerns about scores of bioengineering papers - Nature
- Statnews: FDA approves first new kind of drug to target gonorrhea in decades - statnews.com
- Fiercebiotech: 2026 outlook: Biotech poised to outperform bear markets of ’21-24, analyst says - Fierce Biotech
- Biospace: FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial - BioSpace
- Biospace: FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS - BioSpace
- Bioworld: Nuzolvence, Blujepa win FDA nods for gonorrhea - BioWorld MedTech
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.